Timo Siitonen

1.3k total citations
48 papers, 572 citations indexed

About

Timo Siitonen is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Timo Siitonen has authored 48 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 17 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Timo Siitonen's work include Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Multiple Myeloma Research and Treatments (10 papers). Timo Siitonen is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Multiple Myeloma Research and Treatments (10 papers). Timo Siitonen collaborates with scholars based in Finland, United States and Denmark. Timo Siitonen's co-authors include Eeva‐Riitta Savolainen, Pirjo Koistinen, Marjaana Säily, P. Koistinen, Pentti Mäntymaa, Vuokko L. Kinnula, E. Koivunen, T. Nousiainen, Kari Remes and Esa Jantunen and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Timo Siitonen

45 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timo Siitonen Finland	16	238	229	131	106	78	48	572
Serdar Bedii Omay Türkiye	17	149 0.6×	203 0.9×	138 1.1×	55 0.5×	41 0.5×	41	611
P. Thavasu United Kingdom	8	151 0.6×	279 1.2×	155 1.2×	70 0.7×	43 0.6×	10	644
Zhongzheng Lu China	11	156 0.7×	392 1.7×	121 0.9×	82 0.8×	35 0.4×	11	642
Yuh‐Ching Twu Taiwan	18	269 1.1×	263 1.1×	56 0.4×	83 0.8×	98 1.3×	36	737
Christina Economopoulou Greece	8	96 0.4×	221 1.0×	73 0.6×	99 0.9×	37 0.5×	15	401
Tsuyako Saito Japan	10	77 0.3×	356 1.6×	191 1.5×	41 0.4×	73 0.9×	37	722
Yoko Inaguma Japan	11	120 0.5×	167 0.7×	161 1.2×	47 0.4×	22 0.3×	25	437
David Bastian United States	20	380 1.6×	295 1.3×	164 1.3×	82 0.8×	69 0.9×	42	1.0k
Ina Nepstad Norway	15	319 1.3×	413 1.8×	119 0.9×	96 0.9×	35 0.4×	19	774
Mushtaq Ashraf Pakistan	7	163 0.7×	287 1.3×	72 0.5×	131 1.2×	54 0.7×	10	534

Countries citing papers authored by Timo Siitonen

Since Specialization

Citations

This map shows the geographic impact of Timo Siitonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Siitonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Siitonen more than expected).

Fields of papers citing papers by Timo Siitonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Siitonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Siitonen. The network helps show where Timo Siitonen may publish in the future.

Co-authorship network of co-authors of Timo Siitonen

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Siitonen. A scholar is included among the top collaborators of Timo Siitonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Siitonen. Timo Siitonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeidan, Amer M., Anthony S. Stein, Johanna Rimpiläinen, et al.. (2025). Efficacy, molecular and translational analysis of TP53-mutated HR-MDS with bexmarilimab and azacitidine: Updated results from the bexmab Phase 1/2 study. Blood. 146(Supplement 1). 236–236. 1 indexed citations

Kontro, Mika, Anthony S. Stein, Marja Pyörälä, et al.. (2025). Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial. The Lancet Haematology. 12(7). e516–e528. 2 indexed citations

Kontro, Mika, Anthony S. Stein, Marja Pyörälä, et al.. (2024). Encouraging Efficacy of Bexmarilimab with Azacitidine in Relapsed or Refractory MDS in Bexmab Ph1/2 Study. Blood. 144(Supplement 1). 4265–4265. 1 indexed citations

Kontro, Mika, Anthony S. Stein, Marja Pyörälä, et al.. (2023). Encouraging Efficacy Observed in Bexmab Study: A Phase 1/2 Study to Assess Safety and Efficacy of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies. Blood. 142(Supplement 1). 2915–2915. 2 indexed citations

Hohtari, Helena, Niels Pallisgaard, Matti Kankainen, et al.. (2022). Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica. 107(8). 1971–1976. 1 indexed citations

Vulliamy, Tom, Inderjeet Dokal, Jean Soulier, et al.. (2021). Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease. Blood. 138(Supplement 1). 864–864. 1 indexed citations

Jokelainen, Jari, Timo Siitonen, Outi Laine, et al.. (2020). Characterisation of healthcare utilisation and cost of haemophilia care in real‐life: A 4‐year follow‐up study in Finland. Haemophilia. 27(1). e30–e39.

Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2007). Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Bone Marrow Transplantation. 41(3). 239–244. 16 indexed citations

Siitonen, Timo, T. Timonen, Eeva Juvonen, et al.. (2007). Valproic acid combined with 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 in the treatment of patients with myelodysplastic syndromes. Haematologica. 92(8). 1119–1122. 30 indexed citations

10.

Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2006). Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience. Bone Marrow Transplantation. 37(12). 1093–1098. 21 indexed citations

11.

Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2006). Late non‐relapse mortality among adult autologous stem cell transplant recipients: a nation‐wide analysis of 1482 patients transplanted in 1990–2003. European Journal Of Haematology. 77(2). 114–119. 22 indexed citations

12.

Jantunen, Esa, Juha Salonen, E. Koivunen, et al.. (2004). Invasive fungal infections in autologous stem cell transplant recipients: a nation‐wide study of 1188 transplanted patients. European Journal Of Haematology. 73(3). 174–178. 59 indexed citations

13.

Koistinen, Pirjo, et al.. (2001). p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death. Leukemia Research. 25(12). 1099–1105. 3 indexed citations

14.

Koistinen, P., Timo Siitonen, Pentti Mäntymaa, et al.. (2001). Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system. Leukemia. 15(9). 1433–1441. 31 indexed citations

15.

Mäntymaa, Pentti, Timo Siitonen, Marjaana Säily, et al.. (2000). Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. British Journal of Haematology. 108(3). 574–581. 54 indexed citations

16.

Siitonen, Timo, Pentti Mäntymaa, Marjaana Säily, Eeva‐Riitta Savolainen, & Pirjo Koistinen. (2000). Etoposide-induced apoptosis is not associated with the Fas pathway in acute myeloblastic leukemia cells. Leukemia Research. 24(4). 281–288. 13 indexed citations

17.

Siitonen, Timo, Eeva‐Riitta Savolainen, & P. Koistinen. (1999). Flt‐3 ligand does not induce the growth of peripheral blood granulocyte‐macrophage colony‐forming cells in myeloproliferative disorders. European Journal Of Haematology. 62(2). 103–108. 1 indexed citations

18.

Siitonen, Timo, Aiping Zheng, Eeva‐Riitta Savolainen, & Pirjo Koistinen. (1996). Spontaneous granulocyte-macrophage colony growth by peripheral blood mononuclear cells in myeloproliferative disorders. Leukemia Research. 20(2). 187–195. 8 indexed citations

19.

Siitonen, Timo, et al.. (1996). Effect of mast cell growth factor on clonogenic blast cell growth in acute myelogenous leukemia. Annals of Hematology. 73(2). 71–78. 3 indexed citations

20.

Siitonen, Timo, Ang Zheng, Eeva‐Riitta Savolainen, & P. Koistinen. (1995). The effect of mast cell growth factor on peripheral blood granulocyte‐macrophage colony‐forming cells in methylcellulose in myeloproliferative disorders. European Journal Of Haematology. 55(4). 228–234. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact